Cardiovascular Medical Devices Market Analysis, Size, and Forecast 2025-2029: North America (US, Canada, and Mexico), Europe (France, Germany, Italy, and UK), APAC (China, India, and Japan), and Rest of World (ROW)

Cardiovascular Medical Devices Market Size 2025-2029

The cardiovascular medical devices market size is forecast to increase by USD 21.71 billion at a CAGR of 7.6% between 2024 and 2029.

• The market is driven by the escalating incidence of cardiovascular diseases and the expansion of insurance providers' coverage for related treatments. Market players are responding with innovative business strategies, including product development and strategic collaborations, to capitalize on these opportunities. However, the high cost of cardiovascular procedures poses a significant challenge for both patients and providers, potentially limiting market growth. Artificial intelligence and wireless technologies, such as Al-based electrocardiograms, implantable loop recorders, and event monitors, are also gaining popularity for their ability to improve diagnostic accuracy and patient care.
• Effective cost management and continuous innovation will be essential for market success. As the population ages and cardiovascular diseases become increasingly prevalent, companies must navigate this financial obstacle while maintaining quality and affordability to meet patient needs and remain competitive. Companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis.

What will be the Size of the Cardiovascular Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The Cardiovascular Devices Market encompasses diagnostic monitoring devices, surgical devices, and cardiology devices used to prevent and manage heart disorders, including cardiomyopathy, heart failure, stroke, and heart-related mortality. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, making this market crucial for addressing healthcare resources and improving patient outcomes. Emerging nations are increasingly investing in advanced cardiovascular devices, such as AI-based ECG technology and minimally invasive procedures, to reduce fatal conditions like heart failure and stroke. The market is witnessing significant trends, including the integration of artificial intelligence in diagnostics and the development of more sophisticated surgical devices, such as coronary artery stents.

Cardiovascular Diseases, including heart disorders and heart-related mortality, are major health concerns, and the demand for diagnostic monitoring devices, such as Holter monitors, is on the rise. The market's growth is driven by the need for early detection and effective management of cardiovascular conditions, as well as advancements in technology, such as minimally invasive procedures and AI-based electrocardiogram technology. The Cardiovascular Devices Market is expected to continue growing, as healthcare systems in both developed and emerging nations seek to improve patient care and reduce the burden of cardiovascular diseases. With advancements in technology and a growing focus on preventative care, the market is poised for continued growth and innovation.

How is this Cardiovascular Medical Devices Industry segmented?

The cardiovascular medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

• Product
  • Diagnostic systems
  • Surgical devices
• Disease Type
  • Coronary artery disease
  • Arrhythmia
  • Heart failure
  • Structural heart disease
  • Others
• End-user
  • Hospitals
  • ASCs
  • Specialty clinics
  • Home healthcare settings
  • Rehabilitation centers
• Geography
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
  • APAC
    • China
    • India
    • Japan
  • Rest of World (ROW)

By Product Insights

The Diagnostic systems segment is estimated to witness significant growth during the forecast period. The market encompasses a vast array of technologies and devices designed to diagnose, monitor, and treat heart disorders and diseases. This market includes innovative solutions such as AI-based electrocardiogram (ECG) technology, implantable loop recorders, cardiac CT scans, and minimally invasive procedures for detecting clogged arteries and assessing heart function. Valves, pacemakers, stents, Holter monitors, and electrosurgical procedures are among the essential cardiovascular devices used for treating various heart conditions. The World Health Organization reports that cardiovascular diseases (CVDs) are the leading cause of heart-related mortality worldwide. Fatal conditions like atrial fibrillation, stroke, and heart attacks necessitate advanced diagnostic and monitoring devices.

The diagnostic systems segment, which includes both diagnostic and monitoring systems, is experiencing significant growth due to the increasing prevalence of CVDs, aging populations, and a shift toward home-based care and AI-powered technologies. MRI, echocardiograms, and coronary artery stents are essential diagnostic tools for assessing heart health and detecting coronary disease. Wearable smart devices, such as wireless ECGs and event monitors, enable continuous monitoring and early detection of cardiac conditions. Furthermore, the home healthcare sector and medical tourism sector have fueled the demand for minimally invasive procedures and diagnostic monitoring devices. Innovative technologies, such as the CardioMEMS HF System, mitral valve replacements, and AccuRhythm AI algorithms, are revolutionizing cardiology by providing more accurate and efficient diagnostic and therapeutic solutions.

The market includes a diverse range of devices, from diagnostic and monitoring systems to surgical devices, all aimed at improving heart health and reducing heart-related mortality.

Download Free Sample Report

The Diagnostic systems segment was valued at USD 22.47 billion in 2019 and showed a gradual increase during the forecast period.

The market is also witnessing the integration of artificial intelligence and diagnostic monitoring devices, catheters, and accessories to enhance the overall efficiency and effectiveness of cardiovascular care. The cardiovascular devices market is further driven by the increasing burden of heart disorders, poor eating habits, and sedentary lifestyles leading to heart failure and cardiomyopathy. The dlip-delivery system and occlusion devices are essential surgical devices used in treating various cardiovascular conditions. The market's growth is also fueled by the increasing demand for minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR). The market is witnessing robust growth due to the increasing prevalence of cardiovascular diseases, aging populations, and a shift toward home-based care and AI-powered technologies.

The Cardiovascular Medical Devices Market is witnessing steady growth driven by rising cases of fatal condition related to heart health worldwide. The increasing prevalence of cardiac illnesses has heightened the demand for advanced diagnostic and therapeutic devices. Technologies like PET scans play a vital role in the early detection and monitoring of cardiovascular diseases, improving patient outcomes. Surgical procedures often involve precision tools such as cannulae, essential for safe and effective cardiac interventions. Growing disease awareness campaigns and public health initiatives are encouraging early screenings and proactive management of heart-related conditions. Cardiovascular catheters and guidewires are essential components of these procedures, and their advancements continue to drive market growth.

Regional Analysis

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

View Free PDF Sample

The North American market for cardiovascular medical devices is experiencing significant growth, fueled by the rising prevalence of cardiovascular diseases, such as coronary artery disease (CAD), which affected an estimated 18.2 million American adults or around 6.7% of the adult population as of 2024. CAD, the most common type of heart disease, is a leading cause of death, accounting for one in five fatalities among adults under 65 in the U.S. This expansion is driven by the region's advanced healthcare infrastructure, aging population, and increasing adoption of minimally invasive procedures, including coronary stents, diagnostic catheters, and wearable cardiac monitors.

This market analysis report provides a comprehensive overview of the market growth factors, business strategies, and challenges shaping the future of the cardiovascular medical devices industry. Additionally, the home healthcare sector and medical tourism sector are contributing to the market's growth, with an increasing number of patients opting for the convenience and cost savings offered by these alternatives. The World Health Organization's focus on decentralized clinical trials for cardiovascular diseases and the development of new surgical devices, such as mitral valves and occlusion devices, are also expected to drive market growth. Poor eating habits and heart disorders, including heart failure, stroke, and cardiomyopathy, continue to pose significant health risks, further fueling demand for cardiovascular devices.

MRI, echocardiograms, pacemakers, stents, Holter monitors, electrosurgical procedures, cannulas, and catheters and accessories are essential components of the cardiovascular devices market, with diagnostic monitoring devices and occlusion devices being key areas of innovation. The use of advanced technologies, such as AccuRhythm AI algorithms, is transforming the landscape of cardiovascular care, enabling earlier and more accurate diagnoses and personalized treatment plans. Healthcare resources remain a critical factor in addressing the growing burden of cardiovascular diseases, with ongoing efforts to improve access and affordability.

Market Dynamics

Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the Cardiovascular Medical Devices market drivers leading to the rise in the adoption of Industry?

• The increasing prevalence of cardiac diseases and the expansion of insurance providers serve as the primary drivers for market growth in this sector. The market experiences significant growth due to the increasing prevalence of cardiovascular diseases (CVDs), which remain the leading cause of death worldwide, accounting for approximately 18 million fatalities annually. Factors contributing to this trend include sedentary lifestyles, poor dietary habits, smoking, excessive alcohol intake, and stress, which elevate risk levels for heart disease across diverse age groups and demographics. An aging population further accelerates the prevalence of heart conditions, as age is a primary risk factor for many cardiovascular issues.

• These devices enable early detection and intervention, improving patient outcomes and reducing the risk of complications, including heart attacks, stroke, and atrial fibrillation. Cardiovascular medical devices also play a crucial role in supporting various clinical procedures, such as cannulas and event monitors, ensuring the successful implementation of interventions and enhancing patient care. The World Health Organization (WHO) highlights the importance of access to quality cardiovascular care, highlighting the need for continuous innovation and advancement in this field. Decentralized clinical trials and remote monitoring technologies further expand the reach and accessibility of cardiovascular medical devices, enabling early intervention and better management of cardiovascular conditions in various settings.

What are the Cardiovascular Medical Devices market trends shaping the Industry?

• The use of strategic business approaches is currently a significant trend among market companies. This involves the implementation of well-planned and informed business maneuvers to gain a competitive edge. In the expansive market, companies are implementing innovative strategies to gain a competitive edge. One such approach is Stryker's Sustainability Solutions, which specializes in the reprocessing of single-use cardiovascular diagnostic catheters. This initiative reduces hospital costs, making cardiovascular procedures more affordable for patients and healthcare providers. Stryker offers reprocessed catheter introducer sheaths, such as Agilis NxT, which is utilized in Electrophysiology (EP) procedures.

• Technologies like the CardioMEMS HF System, MRI, coronary artery stents, echocardiograms, coronary disease diagnostics, and Electrocardiograms (ECG) continue to shape the market landscape. Additionally, the home healthcare sector and medical tourism are emerging growth areas. Companies are focusing on enhancing the patient experience and improving the accuracy and efficiency of cardiovascular diagnostic and therapeutic devices. This sheath, manufactured by St. Jude Medical, contributes significantly to EP procedures' success. The cardiovascular devices market is driven by the increasing prevalence of cardiology conditions, such as heart failure, caused by poor eating habits and sedentary lifestyles.

How does Cardiovascular Medical Devices market face challenges during its growth?

• The escalating costs of cardiovascular procedures pose a significant challenge to the growth of the industry. The market faces a notable challenge due to the high cost of procedures involving advanced devices, such as coronary artery bypass grafts (CABG), stent placements, and pacemaker or defibrillator implantations. The expense of these procedures is substantial, encompassing the cost of the devices, surgical complexity, and the requirement for skilled healthcare professionals and advanced facilities. Procedures can range from thousands to tens of thousands of dollars, creating a significant burden for patients and healthcare systems, particularly in areas with limited health insurance coverage or reimbursement structures.

• Cardiovascular diseases, such as cardiomyopathy, require continuous diagnostic monitoring using devices like occlusion devices, Doppler fetal monitors, wireless ECG, and diagnostic monitoring devices. Additionally, catheters and accessories, including the dlip-delivery system and AccuRhythm AI algorithms, are essential components of these procedures. Artificial intelligence plays a crucial role in enhancing the efficiency and accuracy of cardiovascular medical devices, enabling early detection and intervention for various cardiovascular conditions. The integration of AI in cardiovascular devices, such as wireless ECG and diagnostic monitoring devices, can lead to improved patient outcomes and reduced healthcare costs in the long run.

Exclusive Customer Landscape

The cardiovascular medical devices market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the cardiovascular medical devices market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, cardiovascular medical devices market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Abbott Laboratories - The company specializes in producing advanced cardiovascular medical devices, including cardiac resynchronization therapy devices and implantable cardioverter defibrillators, enhancing heart rhythm management for patients.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• Argon Medical Devices Inc.
• B.Braun SE
• BIOTRONIK SE and Co. KG
• Boston Scientific Corp.
• Canon Inc.
• Cardinal Health Inc.
• Edwards Lifesciences Corp.
• Eurocor Tech GmbH
• GE Healthcare Technologies Inc.
• Getinge AB
• Johnson and Johnson Services Inc.
• Lepu Medical Technology Beijing Co. Ltd.
• LivaNova PLC
• Medtronic Plc
• Merit Medical Systems Inc.
• Newtech Medical Devices
• Siemens AG
• Terumo Corp.
• W. L. Gore and Associates Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Cardiovascular Medical Devices Market

• In January 2024, Medtronic, a leading global healthcare solutions company, announced the FDA approval of its new wireless home monitoring system for heart failure patients, Hospitelis Heart Failure. This system aims to improve patient outcomes by enabling remote monitoring and timely intervention (Medtronic Press Release, 2024).
• In March 2024, Abbott Laboratories and Siemens Healthineers entered into a strategic collaboration to integrate Abbott's FreeStyle Libre glucose sensing technology with Siemens Healthineers' cardiovascular imaging systems. This partnership aims to enhance patient care by providing real-time glucose data during cardiovascular procedures (Abbott Laboratories Press Release, 2024).
• In April 2025, Edwards Lifesciences completed the acquisition of Valedicta Therapeutics, a privately held company specializing in transcatheter mitral valve repair and replacement therapies. This acquisition strengthens Edwards' interventional portfolio and expands its presence in the growing transcatheter heart valve market (Edwards Lifesciences Press Release, 2025).
• In May 2025, Boston Scientific received CE Mark approval for its new WATCHMAN FLX Left Atrial Appendage Closure device. This device features a lower profile and improved delivery system, making it easier for physicians to implant and reducing the risk of complications (Boston Scientific Press Release, 2025).

Research Analyst Overview

The cardiovascular devices market continues to evolve, driven by advancements in technology and the growing prevalence of heart disorders. Cardiology devices, such as the Cardiomems HF System and mitral valves, play a crucial role in addressing heart failure, a condition often exacerbated by poor eating habits. MRI and echocardiograms are essential diagnostic tools in cardiovascular care, while home healthcare and medical tourism sectors offer new opportunities for cardiovascular devices. Coronary artery stents and occlusion devices are minimally invasive solutions for treating coronary disease, a leading cause of heart-related mortality. Wearable smart devices and wireless ECGs enable continuous monitoring, enhancing healthcare resources for cardiovascular patients.

Artificial intelligence and diagnostic monitoring devices, including implantable loop recorders and event monitors, are revolutionizing cardiovascular care. The cardiovascular devices market encompasses a wide range of applications, from pacemakers and electrosurgical procedures to catheters and accessories. Ongoing research focuses on improving outcomes for conditions like atrial fibrillation, stroke, and cardiomyopathy, while decentralized clinical trials expand access to innovative treatments. The market's continuous dynamism reflects the evolving nature of heart disorders and the relentless pursuit of better patient care.

The high cost of cardiovascular interventions can deter patients from seeking timely treatment, potentially resulting in worsened health outcomes and increased healthcare costs over time due to delayed care. Despite the benefits, the high cost of these advanced cardiovascular devices and procedures remains a significant barrier to their widespread adoption. Overall, the market is expected to continue growing, driven by the increasing burden of cardiovascular diseases and the ongoing development of innovative solutions to address the evolving needs of patients and healthcare providers. Advanced diagnostic, monitoring, and treatment solutions, such as pacemakers, stents, Holter monitors, electrosurgical procedures, and surgical devices, are in high demand to address the rising incidence of cardiovascular conditions.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Cardiovascular Medical Devices Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Cardiovascular Medical Devices Market Research and Growth Report?

• CAGR of the Cardiovascular Medical Devices industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2025 and 2029
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the cardiovascular medical devices market growth of industry companies

We can help! Our analysts can customize this cardiovascular medical devices market research report to meet your requirements.

Get in touch